About Arthur Suckow
Arthur Suckow is an executive chair at Sinopia Biosciences.
Experience
This experience comes from Arthur Suckow's profile and from SEC filings. For roles taken from filings, the years are when the filings name Arthur Suckow in the role, so the role may have started earlier or lasted longer.
Sinopia Biosciences, Inc. Current
Executive Chair
2025 – Present · San Diego, CA
Develops medicines for people with Parkinson’s disease and other conditions.
TR
Transcera Current
Advisor
2024 – Present
CF
CMT Research Foundation Current
Board of Directors
2023 – Present
AI
Actio Biosciences, Inc. Current
Advisor
2023 – Present
PT
Palm Therapeutics Current
Advisor
2023 – Present
DT
DTxPharma
CEO
2017 – 2023
RT
Regulus Therapeutics
miRNA Therapeutics
2016 – 2017
ME
MedImmune
Diabetes Drug Discovery
2013 – 2016
JJ
Johnson & Johnson
Diabetes Drug Discovery
2010 – 2013
UC
UCSD
NSF Graduate Fellow
2005 – 2009
UD
University of Delaware
Beckman Scholar
2001 – 2004
Key Colleagues at Startups
The people Arthur Suckow works with at each company, as listed on that company's latest Form D.
Sinopia Biosciences, Inc. · Form D, Jul 16, 2026
IF
Iman Famili
COO and director
AB
Aarash Bordbar
CEO, CSO, and Co-Founder, director
BP
Bernhard Palsson
Co-Founder and director